Plasmacytoid Dendritic Cell Development

Advances in Immunology

Volumn 120, Issue , 2013, Pages 105-126

  Shortman, Ken ^a,d   Sathe, Priyanka ^a,b   Vremec, David ^a   Naik, Shalin ^a,c   O'Keeffe, Meredith ^d,e  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d BURNET INSTITUTE   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Dendritic cell development; Dendritic cell lineage; Dendritic cell precursor; Interferon; Plasmacytoid dendritic cell

Indexed keywords

CELL MARKER; CHEMOKINE RECEPTOR CCR9; INTERFERON; RAG 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL POPULATION; CELL SURFACE; CYTOKINE PRODUCTION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; LYMPHOID PROGENITOR CELL; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; STEADY STATE; STEM CELL;

EID: 84884394634     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/B978-0-12-417028-5.00004-1     Document Type: Chapter

References (78)

1. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
2. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000, 404:193-197.
3. Ank N., Iversen M.B., Bartholdy C., Staeheli P., Hartmann R., Jensen U.B., et al. An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. The Journal of Immunology 2008, 180:2474-2485.
4. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature Immunology 2001, 2:1144-1150.
5. Bar-On L., Birnberg T., Lewis K.L., Edelson B.T., Bruder D., Hildner K., et al. CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14745-14750.
6. Bjorck P., Leong H.X., Engleman E.G. Plasmacytoid dendritic cell dichotomy: Identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset. The Journal of Immunology 2011, 186:1477-1485.
7. Blasius A.L., Giurisato E., Cella M., Schreiber R.D., Shaw A.S., Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. The Journal of Immunology 2006, 177:3260-3265.
8. Brasel K., De Smedt T., Smith J.L., Maliszewski C.R. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000, 96:3029-3039.
9. Chen W., Antonenko S., Sederstrom J.M., Liang X., Chan A.S., Kanzler H., et al. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553.
10. Chicha L., Jarrossay D., Manz M.G. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. The Journal of Experimental Medicine 2004, 200:1519-1524.
11. Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
12. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nature Immunology 2004, 5:1219-1226.
13. Corcoran L., Ferrero I., Vremec D., Lucas K., Waithman J., O'Keeffe M., et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. The Journal of Immunology 2003, 170:4926-4932.
14. D'Amico A., Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. The Journal of Experimental Medicine 2003, 198:293-303.
15. Diao J., Winter E., Chen W., Cantin C., Cattral M.S. Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow. The Journal of Immunology 2004, 173:1826-1833.
16. Esashi E., Wang Y.H., Perng O., Qin X.F., Liu Y.J., Watowich S.S. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 2008, 28:509-520.
17. Fancke B., Suter M., Hochrein H., O'Keeffe M. M-CSF: A novel plasmacytoid and conventional dendritic cell poietin. Blood 2008, 111:150-159.
18. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor E2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
19. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. The Journal of Experimental Medicine 2002, 195:953-958.
20. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nature Reviews Immunology 2008, 8:594-606.
21. Hadeiba H., Lahl K., Edalati A., Oderup C., Habtezion A., Pachynski R., et al. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 2012, 36:438-450.
22. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nature Immunology 2008, 9:1253-1260.
23. Izon D., Rudd K., DeMuth W., Pear W.S., Clendenin C., Lindsley R.C., et al. A common pathway for dendritic cell and early B cell development. The Journal of Immunology 2001, 167:1387-1392.
24. Kamogawa-Schifter Y., Ohkawa J., Namiki S., Arai N., Arai K., Liu Y. Ly49Q defines 2 pDC subsets in mice. Blood 2005, 105:2787-2792.
25. Karsunky H., Merad M., Cozzio A., Weissman I.L., Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. The Journal of Experimental Medicine 2003, 198:305-313.
26. Kingston D., Schmid M.A., Onai N., Obata-Onai A., Baumjohann D., Manz M.G. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009, 114:835-843.
27. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
28. Laouar Y., Welte T., Fu X.Y., Flavell R.A. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 2003, 19:903-912.
29. Lauterbach H., Bathke B., Gilles S., Traidl-Hoffmann C., Luber C.A., Fejer G., et al. Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC. The Journal of Experimental Medicine 2010, 207:2703-2717.
30. Lee C.-K., Chen Y.-L., Chen T.-T., Pac L.-M., Wesoly J., Bluyssen H.A.R. A type 1 IFN/Flt3 ligand axis augments plasmacytoid dendritic cell development from common lymphoid progenitors 2013, Submitted for publication.
31. Liu Y.J. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annual Review of Immunology 2005, 23:275-306.
32. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
33. MacDonald K.P., Rowe V., Bofinger H.M., Thomas R., Sasmono T., Hume D.A., et al. The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. The Journal of Immunology 2005, 175:1399-1405.
34. Manz M.G., Traver D., Miyamoto T., Weissman I.L., Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001, 97:3333-3341.
35. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
36. Merad M., Manz M.G. Dendritic cell homeostasis. Blood 2009, 113:3418-3427.
37. Nagasawa M., Schmidlin H., Hazekamp M.G., Schotte R., Blom B. Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. European Journal of Immunology 2008, 38:2389-2400.
38. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nature Immunology 2006, 7:663-671.
39. Naik S.H., Perie L., Swart E., Gerlach C., van Rooij N., de Boer R.J., et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 2013, 496:229-232.
40. Naik S.H., Proietto A.I., Wilson N.S., Dakic A., Schnorrer P., Fuchsberger M., et al. Cutting edge: Generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. The Journal of Immunology 2005, 174:6592-6597.
41. Naik S.H., Sathe P., Park H.-Y., Metcalf D., Proietto A.I., Dakic A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nature Immunology 2007, 8:1217-1226.
42. O'Keeffe M., Fancke B., Suter M., Ramm G., Clark J., Wu L., et al. Nonplasmacytoid, high IFN-alpha-producing, bone marrow dendritic cells. The Journal of Immunology 2012, 188:3774-3783.
43. O'Keeffe M., Hochrein H., Vremec D., Caminschi I., Miller J.L., Anders E.M., et al. Mouse plasmacytoid cells: Long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. The Journal of Experimental Medicine 2002, 196:1307-1319.
44. O'Keeffe M., Hochrein H., Vremec D., Pooley J., Evans R., Woulfe S., et al. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 2002, 99:2122-2130.
45. Omatsu Y., Iyoda T., Kimura Y., Maki A., Ishimori M., Toyama-Sorimachi N., et al. Development of murine plasmacytoid dendritic cells defined by increased expression of an inhibitory NK receptor, Ly49Q. The Journal of Immunology 2005, 174:6657-6662.
46. Onai N., Kurabayashi K., Hosoi-Amaike M., Toyama-Sorimachi N., Matsusima K., Inaba K., et al. A clonogenic progenitor with prominent plasmacytoid dendritic cell potential. Immunity 2013, 38(5):943-957.
47. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., Manz M.G. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nature Immunology 2007, 8:1207-1216.
48. Onai N., Obata-Onai A., Tussiwand R., Lanzavecchia A., Manz M.G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. The Journal of Experimental Medicine 2006, 203:227-238.
49. Pelayo R., Hirose J., Huang J., Garrett K.P., Delogu A., Busslinger M., et al. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 2005, 105:4407-4415.
50. Proietto A.I., Mittag D., Roberts A.W., Sprigg N., Wu L. The equivalents of human blood and spleen dendritic cell subtypes can be generated in vitro from human CD34(+) stem cells in the presence of fms-like tyrosine kinase 3 ligand and thrombopoietin. Cellular and molecular immunology 2012, 9:446-454.
51. Pulendran B., Banchereau J., Burkeholder S., Kraus E., Guinet E., Chalouni C., et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. The Journal of Immunology 2000, 165:566-572.
52. Robbins S.H., Walzer T., Dembele D., Thibault C., Defays A., Bessou G., et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biology 2008, 9:R17.
53. Sathe P., Pooley J., Vremec D., Mintern J., Jin J.O., Wu L., et al. The acquisition of antigen cross-presentation function by newly formed dendritic cells. The Journal of Immunology 2011, 186:5184-5192.
54. Sathe P., Vremec D., Wu L., Corcoran L., Shortman K. Convergent differentiation: Myeloid and lymphoid pathways to murine plasmacytoid dendritic cells. Blood 2013, 121:11-19.
55. Schlitzer A., Heiseke A.F., Einwachter H., Reindl W., Schiemann M., Manta C.P., et al. Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood 2012, 119:6063-6071.
56. Schlitzer A., Loschko J., Mair K., Vogelmann R., Henkel L., Einwachter H., et al. Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs. Blood 2011, 117:6562-6570.
57. Schmid M.A., Kingston D., Boddupalli S., Manz M.G. Instructive cytokine signals in dendritic cell lineage commitment. Immunology Reviews 2010, 234:32-44.
58. Segura E., Wong J., Villadangos J.A. Cutting edge: B220+ CCR9- dendritic cells are not plasmacytoid dendritic cells but are precursors of conventional dendritic cells. The Journal of Immunology 2009, 183:1514-1517.
59. Shigematsu H., Reizis B., Iwasaki H., Mizuno S., Hu D., Traver D., et al. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004, 21:43-53.
60. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nature Reviews Immunology 2002, 2:151-161.
61. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nature Reviews Immunology 2007, 7:19-30.
62. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
63. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunology Reviews 2010, 234:142-162.
64. Swiecki M., Gilfillan S., Vermi W., Wang Y., Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010, 33:955-966.
65. Tailor P., Tamura T., Morse H.C., Ozato K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 2008, 111:1942-1945.
66. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., et al. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 2000, 290:2152-2154.
67. Tsujimura H., Tamura T., Ozato K. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. The Journal of Immunology 2003, 170:1131-1135.
68. Tussiwand R., Lee W.-L., Murphy T.L., Mashayekhi M., Kc W., Albring J.C., et al. Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012, 490:502-507.
69. Vogt T.K., Link A., Perrin J., Finke D., Luther S.A. Novel function for interleukin-7 in dendritic cell development. Blood 2009, 113:3961-3968.
70. Vollstedt S., O'Keeffe M., Ryf B., Glanzmann B., Hochrein H., Suter M. The long-term but not the short-term antiviral effect of IFN-α depends on Flt3 ligand and pDC. European Journal of Immunology 2006, 36:1231-1240.
71. Vremec D., O'Keeffe M., Hochrein H., Fuchsberger M., Caminschi I., Lahoud M., et al. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 2007, 109:1165-1173.
72. Waskow C., Liu K., Darrasse-Jeze G., Guermonprez P., Ginhoux F., Merad M., et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nature Immunology 2008, 9:676-683.
73. Wendland M., Czeloth N., Mach N., Malissen B., Kremmer E., Pabst O., et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proceedings of the National Academy of United States of America 2007, 104:6347-6352.
74. Wu L., D'Amico A., Hochrein H., O'Keeffe M., Shortman K., Lucas K. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 2001, 98:3376-3382.
75. Yang G.X., Lian Z.X., Kikuchi K., Moritoki Y., Ansari A.A., Liu Y.J., et al. Plasmacytoid dendritic cells of different origins have distinct characteristics and function: Studies of lymphoid progenitors versus myeloid progenitors. The Journal of Immunology 2005, 175:7281-7287.
76. Young L.J., Wilson N.S., Schnorrer P., Proietto A., ten Broeke T., Matsuki Y., et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nature Immunology 2008, 9:1244-1252.
77. Zhang J., Raper A., Sugita N., Hingorani R., Salio M., Palmowski M.J., et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 2006, 107:3600-3608.
78. Zuniga E.I., McGavern D.B., Pruneda-Paz J.L., Teng C., Oldstone M.B. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nature Immunology 2004, 5:1227-1234.